Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis

Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis

Abstract Background The clinical value of combined local radiation and epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) for medically inoperable and TKI-naïve early-stage lung adenocarcinoma patients with EGFR mutations has not yet been determined. In this study, we aimed to...

Full description

Bibliographic Details
Main Authors: Yuemei Sun, Mengwan Wu, Mingxiu Zhou, Xing Luo, Yan Guo, Hansong Bai, Zican Zhang, Wei Tian, Xiaoshan Wang, Yifeng Bai, Xueqiang Zhu, Haixia Pan, Ying Deng, Honglin Hu, Jianling Xia, Xinbao Hao, Liangfu Han, Min Wei, Yingyi Liu, Ming Zeng
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Cancer
Subjects:
EGFR
Inoperable
Lung adenocarcinoma
Radiation therapy
TKI
Online Access:http://link.springer.com/article/10.1186/s12885-020-07122-7

Internet

http://link.springer.com/article/10.1186/s12885-020-07122-7

Similar Items